Open Radical Cystectomy

  • J. Joy LeeEmail author
  • Dipen J. Parekh
  • Mark L. Gonzalgo


Open radical cystectomy with pelvic lymphadenectomy remains the gold standard for patients with clinically localized muscle-invasive bladder cancer. Other indications for radical cystectomy include carcinoma in-situ (cis) or high-grade tumors refractory to intravesical chemo- or immunotherapy, or recurrent multifocal superficial tumors unable to be managed adequately with repeat transurethral resection. With the advent of laparoscopic/robotic technology, cystectomy can also be performed using minimally invasive surgical approaches. Ongoing multi-institutional randomized prospective trials are evaluating whether safety, oncologic control, clinical outcomes, and cost efficacy are comparable between the two techniques. Preoperative considerations, including full staging, neoadjuvant therapy, type of diversion, and preparation for surgery are all of paramount importance in preparing for radical cystectomy. Surgical technique specific to male and female cystectomy will be discussed, as well as pelvic lymphadenectomy and form of diversion. Lastly, postoperative management and early and late complications are outlined to help guide accurate and forthright discussions with the patient.


Open cystectomy Radical cystectomy Invasive bladder cancer Surgical technique Urinary diversion Pelvic lymphadenectomy 


  1. 1.
    Whitmore Jr WF, Marshall VF. Radical total cystectomy for cancer of the bladder: 230 consecutive cases five years later. J Urol. 1962;87:853–68.PubMedGoogle Scholar
  2. 2.
    Stein JP, Lieskovsky G, Cote R, Groshen S, Feng AC, Boyd S, et al. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. J Clin Oncol. 2001;19(3):666–75.PubMedGoogle Scholar
  3. 3.
    Ghoneim MA, Abdel-Latif M, el-Mekresh M, Abol-Enein H, Mosbah A, Ashamallah A, et al. Radical cystectomy for carcinoma of the bladder: 2,720 consecutive cases 5 years later. J Urol. 2008;180(1):121–7.PubMedCrossRefGoogle Scholar
  4. 4.
    Babjuk M, Oosterlinck W, Sylvester R, Kaasinen E, Böhle A, Palou-Redorta J, et al. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder. Eur Urol. 2008;54(2):303–14.PubMedCrossRefGoogle Scholar
  5. 5.
    Shariat SF, Karakiewicz PI, Palapattu GS, Lotan Y, Rogers CG, Amiel GE, et al. Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium. J Urol. 2006;176(6 Pt 1):2414–22. discussion 2422.PubMedCrossRefGoogle Scholar
  6. 6.
    Gondo T, Yoshioka K, Nakagami Y, Okubo H, Hashimoto T, Satake N, et al. Robotic versus open radical cystectomy: prospective comparison of perioperative and pathologic outcomes in Japan. Jpn J Clin Oncol. 2012;42(7):625–31.PubMedCrossRefGoogle Scholar
  7. 7.
    Pruthi RS, Nielsen ME, Nix J, Smith A, Schultz H, Wallen EM. Robotic radical cystectomy for bladder cancer: surgical and pathological outcomes in 100 consecutive cases. J Urol. 2010;183(2):510–4.PubMedCrossRefGoogle Scholar
  8. 8.
    Wang GJ, Barocas DA, Raman JD, Scherr DS. Robotic vs open radical cystectomy: prospective comparison of perioperative outcomes and pathological measures of early oncological efficacy. BJU Int. 2008;101(1): 89–93.PubMedGoogle Scholar
  9. 9.
    Smith AB, Raynor M, Amling CL, Busby JE, Castle E, Davis R, et al. Multi-institutional analysis of robotic radical cystectomy for bladder cancer: perioperative outcomes and complications in 227 patients. J Laparoendosc Adv Surg Tech A. 2012;22(1):17–21.PubMedCrossRefGoogle Scholar
  10. 10.
    Styn NR, Montgomery JS, Wood DP, Hafez KS, Lee CT, Tallman C, et al. Matched comparison of robotic-assisted and open radical cystectomy. Urology. 2012;79(6):1303–8.PubMedCrossRefGoogle Scholar
  11. 11.
    Parekh DJ, Messer J, Fitzgerald J, Ercole B, Svatek R. Perioperative outcomes and oncologic efficacy from a pilot prospective randomized clinical trial of open versus robotic assisted radical cystectomy. J Urol. 2013;189(2):474–9.PubMedCrossRefGoogle Scholar
  12. 12.
    Nix J, Smith A, Kurpad R, Nielsen ME, Wallen EM, Pruthi RS. Prospective randomized controlled trial of robotic versus open radical cystectomy for bladder cancer: perioperative and pathologic results. Eur Urol. 2010;57(2):196–201.PubMedCrossRefGoogle Scholar
  13. 13.
    Lawrentschuk N, Lee ST, Scott AM. Current role of PET, CT, MR for invasive bladder cancer. Curr Urol Rep. 2013;14(2):84–9.PubMedCrossRefGoogle Scholar
  14. 14.
    Kibel AS, Dehdashti F, Katz MD, Klim AP, Grubb RL, Humphrey PA, et al. Prospective study of [18F]fluorodeoxyglucose positron emission tomography/computed tomography for staging of muscle-invasive bladder carcinoma. J Clin Oncol. 2009;27(26): 4314–20.PubMedCentralPubMedCrossRefGoogle Scholar
  15. 15.
    Skinner DG, Lieskovsky G. Contemporary cystectomy with pelvic node dissection compared to preoperative radiation therapy plus cystectomy in management of invasive bladder cancer. J Urol. 1984;131(6):1069–72.PubMedGoogle Scholar
  16. 16.
    Meeks JJ, Bellmunt J, Bochner BH, Clarke NW, Daneshmand S, Galsky MD, et al. A systematic review of neoadjuvant and adjuvant chemotherapy for muscle-invasive bladder cancer. Eur Urol. 2012;62(3): 523–33.PubMedCrossRefGoogle Scholar
  17. 17.
    Grossman HB, Natale RB, Tangen CM, Speights VO, Vogelzang NJ, Trump DL, et al. Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer. N Engl J Med. 2003;349(9):859–66.PubMedCrossRefGoogle Scholar
  18. 18.
    von der Maase H, Sengelov L, Roberts JT, Ricci S, Dogliotti L, Oliver T, et al. Long-term survival results of a randomized trial comparing gemcitabine plus cisplatin, with methotrexate, vinblastine, doxorubicin, plus cisplatin in patients with bladder cancer. J Clin Oncol. 2005;23(21):4602–8.PubMedCrossRefGoogle Scholar
  19. 19.
    Advanced Bladder Cancer (ABC) Meta-analysis Collaboration. Neoadjuvant chemotherapy in invasive bladder cancer: update of a systematic review and meta-analysis of individual patient data advanced bladder cancer (ABC) meta-analysis collaboration. Eur Urol. 2005;8(2):202–5. discussion 205–206.Google Scholar
  20. 20.
    Koga F, Kihara K, Yoshida S, Yokoyama M, Saito K, Masuda H, et al. Selective bladder-sparing protocol consisting of induction low-dose chemoradiotherapy plus partial cystectomy with pelvic lymph node dissection against muscle-invasive bladder cancer: oncological outcomes of the initial 46 patients. BJU Int. 2012;109(6):860–6.PubMedCrossRefGoogle Scholar
  21. 21.
    Shipley WU, Kaufman DS, Heney NM, Althausen AF, Zietman AL. An update of combined modality therapy for patients with muscle invading bladder cancer using selective bladder preservation or cystectomy. J Urol. 1999;162(2):445–50. discussion 450–451.PubMedCrossRefGoogle Scholar
  22. 22.
    Knoedler JJ, Boorjian SA, Kim SP, Weight CJ, Thapa P, Tarrell RF, et al. Does partial cystectomy compromise oncologic outcomes for patients with bladder cancer compared to radical cystectomy? A matched case-control analysis. J Urol. 2012;188(4):1115–9.PubMedCrossRefGoogle Scholar
  23. 23.
    Capitanio U, Isbarn H, Shariat SF, Jeldres C, Zini L, Saad F, et al. Partial cystectomy does not undermine cancer control in appropriately selected patients with urothelial carcinoma of the bladder: a population-based matched analysist. Urology. 2009;74(4):858–64.PubMedCrossRefGoogle Scholar
  24. 24.
    Kassouf W, Swanson D, Kamat AM, Leibovici D, Siefker-Radtke A, Munsell MF, et al. Partial cystectomy for muscle invasive urothelial carcinoma of the bladder: a contemporary review of the M. D. Anderson Cancer Center experience. J Urol. 2006;175(6):2058–62.PubMedCrossRefGoogle Scholar
  25. 25.
    Holzbeierlein JM, Lopez-Corona E, Bochner BH, Herr HW, Donat SM, Russo P, et al. Partial cystectomy: a contemporary review of the Memorial Sloan-Kettering Cancer Center experience and recommendations for patient selection. J Urol. 2004;172(3):878–81.PubMedCrossRefGoogle Scholar
  26. 26.
    Davidsson T, Wullt B, Könyves J, Månsson A, Månsson K. Urinary diversion and bladder substitution in patients with bladder cancer. Urol Oncol. 2000;5(5):224–31.PubMedCrossRefGoogle Scholar
  27. 27.
    Gschwend JE, May F, Paiss T, Gottfried HW, Hautmann RE. High-dose pelvic irradiation followed by ileal neobladder urinary diversion: complications and long-term results. Br J Urol. 1996;77(5):680–3.PubMedCrossRefGoogle Scholar
  28. 28.
    Hautmann RE, de Petriconi R, Volkmer BG. Neobladder formation after pelvic irradiation. World J Urol. 2009;27(1):57–62.PubMedCrossRefGoogle Scholar
  29. 29.
    Parekh DJ, Donat SM. Urinary diversion: options, patient selection, and outcomes. Semin Oncol. 2007;34(2):98–109.PubMedCrossRefGoogle Scholar
  30. 30.
    Raynor MC, Lavien G, Nielsen M, Wallen EM, Pruthi RS. Elimination of preoperative mechanical bowel preparation in patients undergoing cystectomy and urinary diversion. Urol Oncol. 2013;31(1):32–5.PubMedCrossRefGoogle Scholar
  31. 31.
    Picozzi S, Ricci C, Gaeta M, Ratti D, Macchi A, Casellato S, et al. Upper urinary tract recurrence following radical cystectomy for bladder cancer: a meta-analysis on 13,185 patients. J Urol. 2012;188(6): 2046–54.PubMedCrossRefGoogle Scholar
  32. 32.
    Furukawa J, Miyake H, Hara I, Takenaka A, Fujisawa M. Upper urinary tract recurrence following radical cystectomy for bladder cancer. Int J Urol. 2007;14(6):496–9.PubMedCrossRefGoogle Scholar
  33. 33.
    Casanova GA, Springer JP, Gerber E, Studer UE. Urodynamic and clinical aspects of ileal low pressure bladder substitutes. Br J Urol. 1993;72(5 Pt 2):728–35.PubMedCrossRefGoogle Scholar
  34. 34.
    Hautmann RE, Paiss T, de Petriconi R. The ileal neobladder in women: 9 years of experience with 18 patients. J Urol. 1996;155(1):76–81.PubMedCrossRefGoogle Scholar
  35. 35.
    Chang SS, Cole E, Cookson MS, Peterson M, Smith Jr JA. Preservation of the anterior vaginal wall during female radical cystectomy with orthotopic urinary diversion: technique and results. J Urol. 2002;168(4 Pt 1):1442–5.PubMedCrossRefGoogle Scholar
  36. 36.
    Ali-El-Dein B, Gomha M, Ghoneim MA. Critical evaluation of the problem of chronic urinary retention after orthotopic bladder substitution in women. J Urol. 2002;168(2):587–92.PubMedCrossRefGoogle Scholar
  37. 37.
    Colleselli K, Stenzl A, Eder R, Strasser H, Poisel S, Bartsch G. The female urethral sphincter: a morphological and topographical study. J Urol. 1998;160(1): 49–54.PubMedCrossRefGoogle Scholar
  38. 38.
    Stein JP, Cote RJ, Freeman JA, Esrig D, Elmajian DA, Groshen S, et al. Indications for lower urinary tract reconstruction in women after cystectomy for bladder cancer: a pathological review of female cystectomy specimens. J Urol. 1995;154(4):1329–33.PubMedCrossRefGoogle Scholar
  39. 39.
    Herr HW, Bochner BH, Dalbagni G, Donat SM, Reuter VE, Bajorin DF. Impact of the number of lymph nodes retrieved on outcome in patients with muscle invasive bladder cancer. J Urol. 2002;167(3):1295–8.PubMedCrossRefGoogle Scholar
  40. 40.
    Herr HW. Extent of surgery and pathology evaluation has an impact on bladder cancer outcomes after radical cystectomy. Urology. 2003;61(1):105–8.PubMedCrossRefGoogle Scholar
  41. 41.
    Stein JP, Skinner DG. The role of lymphadenectomy in high-grade invasive bladder cancer. Urol Clin North Am. 2005;32(2):187–97.PubMedCrossRefGoogle Scholar
  42. 42.
    Stein JP. Lymphadenectomy in bladder cancer: how high is “high enough”? Urol Oncol. 2006;24(4):349–55.PubMedCrossRefGoogle Scholar
  43. 43.
    Poulsen AL, Horn T, Steven K. Radical cystectomy: extending the limits of pelvic lymph node dissection improves survival for patients with bladder cancer confined to the bladder wall. J Urol. 1998;160(6 Pt 1):2015–9. discussion 2020.PubMedGoogle Scholar
  44. 44.
    Compton CC, Fielding LP, Burgart LJ, Conley B, Cooper HS, Hamilton SR, et al. Prognostic factors in colorectal cancer. College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med. 2000;124(7):979–94.PubMedGoogle Scholar
  45. 45.
    Wright JL, Lin DW, Porter MP. The association between extent of lymphadenectomy and survival among patients with lymph node metastases undergoing radical cystectomy. Cancer. 2008;112(11): 2401–8.PubMedCrossRefGoogle Scholar
  46. 46.
    Stein JP, Cai J, Groshen S, Skinner DG. Risk factors for patients with pelvic lymph node metastases following radical cystectomy with en bloc pelvic lymphadenectomy: concept of lymph node density. J Urol. 2003;170(1):35–41.PubMedCrossRefGoogle Scholar
  47. 47.
    Stein JP, Penson DF, Cai J, Miranda G, Skinner EC, Dunn MA, et al. Radical cystectomy with extended lymphadenectomy: evaluating separate package versus en bloc submission for node positive bladder cancer. J Urol. 2007;177(3):876–81. discussion 881–882.PubMedCrossRefGoogle Scholar
  48. 48.
    Bochner BH, Cho D, Herr HW, Donat M, Kattan MW, Dalbagni G. Prospectively packaged lymph node dissections with radical cystectomy: evaluation of node count variability and node mapping. J Urol. 2004;172(4 Pt 1):1286–90.PubMedCrossRefGoogle Scholar
  49. 49.
    Studer UE, Varol C, Danuser H. Orthotopic ileal neobladder. BJU Int. 2004;93(1):183–93.PubMedCrossRefGoogle Scholar
  50. 50.
    Rowland RG, Mitchell ME, Bihrle R, Kahnoski RJ, Piser JE. Indiana continent urinary reservoir. J Urol. 1987;137(6):1136–9.PubMedGoogle Scholar
  51. 51.
    Le Duc A, Camey M, Teillac P. An original antireflux ureteroileal implantation technique: long-term followup. J Urol. 1987;137(6):1156–8.PubMedGoogle Scholar
  52. 52.
    Leadbetter WF, Clarke BG. Five years’ experience with uretero-enterostomy by the combined technique. J Urol. 1955;73(1):67–82.PubMedGoogle Scholar
  53. 53.
    Goodwin WE, Harris AP, Kaufman JJ, Beal JM. Open, transcolonic ureterointestinal anastomosis; a new approach. Surg Gynecol Obstet. 1953;97(3):295–300.PubMedGoogle Scholar
  54. 54.
    Wiesner C, Stein R, Pahernik S, Hähn K, Melchior SW, Thüroff JW. Long-term follow-up of the intussuscepted ileal nipple and the in situ, submucosally embedded appendix as continence mechanisms of continent urinary diversion with the cutaneous ileocecal pouch (Mainz pouch I). J Urol. 2006;176(1):155–9. discussion 159–160.PubMedCrossRefGoogle Scholar
  55. 55.
    Stein JP, Daneshmand S, Dunn M, Garcia M, Lieskovsky G, Skinner DG. Continent right colon reservoir using a cutaneous appendicostomy. Urology. 2004;63(3):577–80. discussion 580–581.PubMedCrossRefGoogle Scholar
  56. 56.
    Ramirez JA, McIntosh AG, Strehlow R, Lawrence VA, Parekh DJ, Svatek RS. Definition, incidence, risk factors, and prevention of paralytic ileus following radical cystectomy: a systematic review. Eur Urol. 2013;64:688.CrossRefGoogle Scholar
  57. 57.
    Hilton WM, Lotan Y, Parekh DJ, Basler JW, Svatek RS. Alvimopan for prevention of postoperative paralytic ileus in radical cystectomy patients: a cost-effectiveness analysis. BJU Int. 2013;111(7):1054–60.PubMedCrossRefGoogle Scholar
  58. 58.
    Stein JP, Skinner DG. Surgical atlas. Radical cystectomy. BJU Int. 2004;94(1):197–221.PubMedCrossRefGoogle Scholar
  59. 59.
    Hautmann RE, de Petriconi RC, Volkmer BG. Lessons learned from 1,000 neobladders: the 90-day complication rate. J Urol. 2010;184(3):990–4. quiz 1235.PubMedCrossRefGoogle Scholar
  60. 60.
    De Nunzio C, Cindolo L, Leonardo C, Antonelli A, Ceruti C, Franco G, et al. Analysis of radical cystectomy and urinary diversion complications with the Clavien classification system in an Italian real life cohort. Eur J Surg Oncol. 2013;39(7):792–8.PubMedCrossRefGoogle Scholar
  61. 61.
    Shabsigh A, Korets R, Vora KC, Brooks CM, Cronin AM, Savage C, et al. Defining early morbidity of radical cystectomy for patients with bladder cancer using a standardized reporting methodology. Eur Urol. 2009;55(1):164–74.PubMedCrossRefGoogle Scholar
  62. 62.
    Hautmann RE, Abol-Enein H, Davidsson T, Gudjonsson S, Hautmann SH, Holm HV, et al. ICUD-EAU International Consultation on Bladder Cancer 2012: urinary diversion. Eur Urol. 2013;63(1):67–80.PubMedCrossRefGoogle Scholar
  63. 63.
    Hautmann RE, Volkmer BG, Schumacher MC, Gschwend JE, Studer UE. Long-term results of standard procedures in urology: the ileal neobladder. World J Urol. 2006;24(3):305–14.PubMedCrossRefGoogle Scholar
  64. 64.
    Kessler TM, Burkhard FC, Perimenis P, Danuser H, Thalmann GN, Hochreiter WW, et al. Attempted nerve sparing surgery and age have a significant effect on urinary continence and erectile function after radical cystoprostatectomy and ileal orthotopic bladder substitution. J Urol. 2004;172(4 Pt 1):1323–7.PubMedCrossRefGoogle Scholar
  65. 65.
    Tchetgen MB, Sanda MG, Montie JE, Faerber GJ. Collagen injection for the treatment of incontinence after cystectomy and orthotopic neobladder reconstruction in women. J Urol. 2000;163(1):212–4.PubMedCrossRefGoogle Scholar
  66. 66.
    Quek ML, Ginsberg DA, Wilson S, Skinner EC, Stein JP, Skinner DG. Pubovaginal slings for stress urinary incontinence following radical cystectomy and orthotopic neobladder reconstruction in women. J Urol. 2004;172(1):219–21.PubMedCrossRefGoogle Scholar
  67. 67.
    Simma-Chiang V, Ginsberg DA, Teruya KK, Boyd SD. Outcomes of artificial urinary sphincter placement in men after radical cystectomy and orthotopic urinary diversions for the treatment of stress urinary incontinence: the University of Southern California experience. Urology. 2012;79(6):1397–401.PubMedCrossRefGoogle Scholar
  68. 68.
    Jin X-D, Roethlisberger S, Burkhard FC, Birkhaeuser F, Thoeny HC, Studer UE. Long-term renal function after urinary diversion by ileal conduit or orthotopic ileal bladder substitution. Eur Urol. 2012;61(3): 491–7.PubMedCrossRefGoogle Scholar
  69. 69.
    Lin DW, Bush WH, Mayo ME. Endourological treatment of ureteroenteric strictures: efficacy of Acucise endoureterotomy. J Urol. 1999;162(3 Pt 1):696–8.PubMedCrossRefGoogle Scholar
  70. 70.
    Schöndorf D, Meierhans-Ruf S, Kiss B, Giannarini G, Thalmann GN, Studer UE, et al. Ureteroileal strictures after urinary diversion with an ileal segment - is there a place for endourological treatment at all? J Urol. 2013;190(2):585–90.PubMedCrossRefGoogle Scholar
  71. 71.
    Shaaban AA, Abdel-Latif M, Mosbah A, Gad H, Eraky I, Ali-El-Dein B, et al. A randomized study comparing an antireflux system with a direct ureteric anastomosis in patients with orthotopic ileal neobladders. BJU Int. 2006;97(5):1057–62.PubMedCrossRefGoogle Scholar
  72. 72.
    Pantuck AJ, Han KR, Perrotti M, Weiss RE, Cummings KB. Ureteroenteric anastomosis in continent urinary diversion: long-term results and complications of direct versus nonrefluxing techniques. J Urol. 2000;163(2):450–5.PubMedCrossRefGoogle Scholar
  73. 73.
    Stein JP, Ginsberg DA, Skinner DG. Indications and technique of the orthotopic neobladder in women. Urol Clin North Am. 2002;29(3):725–34. xi.PubMedCrossRefGoogle Scholar
  74. 74.
    Stein JP, Grossfeld GD, Freeman JA, Esrig D, Ginsberg DA, Cote RJ, et al. Orthotopic lower urinary tract reconstruction in women using the Kock ileal neobladder: updated experience in 34 patients. J Urol. 1997;158(2):400–5.PubMedCrossRefGoogle Scholar
  75. 75.
    Rapp DE, O’connor RC, Katz EE, Steinberg GD. Neobladder-vaginal fistula after cystectomy and orthotopic neobladder construction. BJU Int. 2004;94(7):1092–5. discussion 1095.PubMedCrossRefGoogle Scholar
  76. 76.
    Tunuguntla HSGR, Manoharan M, Gousse AE. Management of neobladder-vaginal fistula and stress incontinence following radical cystectomy in women: a review. World J Urol. 2005;23(4):231–5.PubMedCrossRefGoogle Scholar
  77. 77.
    Stein JP, Clark P, Miranda G, Cai J, Groshen S, Skinner DG. Urethral tumor recurrence following cystectomy and urinary diversion: clinical and pathological characteristics in 768 male patients. J Urol. 2005;173(4):1163–8.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2015

Authors and Affiliations

  • J. Joy Lee
    • 1
    Email author
  • Dipen J. Parekh
    • 2
  • Mark L. Gonzalgo
    • 3
  1. 1.Department of UrologyStanford University School of MedicineStanfordUSA
  2. 2.Department of UrologyUniversity of Miami Miller School of MedicineMiamiUSA
  3. 3.Department of UrologyUniversity of Miami Miller School of MedicineMiamiUSA

Personalised recommendations